Improvements In Health-Related Quality Of Life From Asteria I & II: Phase III Studies To Evaluate The Efficacy and Safety Of Omalizumab In Patients With Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic Despite H1 Antihistamine Treatment

✍ Scribed by Raimundo, Karina; Zazzali, James; Trzaskoma, Benjamin; Rosen, Karin

• Book ID: 122246563
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 43 KB
• Volume: 133
• Category: Article
• ISSN: 1097-6825
• DOI: 10.1016/j.jaci.2013.12.437